Mark Bagnall

Founder of Phenomix Sciences

Mark Bagnall

Backed by

Sources

Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development — 2024-05

Browse all founders · Browse investors